Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

A randomized controlled trial of exercise to prevent muscle mass and functional loss in elderly hemodialysis patients: Rationale, study design, and baseline sample.

Chan KN, Chen Y, Lit Y, Massaband P, Kiratli J, Rabkin R, Myers JN.

Contemp Clin Trials Commun. 2019 Apr 19;15:100365. doi: 10.1016/j.conctc.2019.100365. eCollection 2019 Sep.

2.

Prehabilitation for kidney transplant candidates: Is it time?

Cheng XS, Myers JN, Chertow GM, Rabkin R, Chan KN, Chen Y, Tan JC.

Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13020. Epub 2017 Jul 10. Review.

PMID:
28564126
3.

Endurance exercise and growth hormone improve bone formation in young and growth-retarded chronic kidney disease rats.

Troib A, Guterman M, Rabkin R, Landau D, Segev Y.

Nephrol Dial Transplant. 2016 Aug;31(8):1270-9. doi: 10.1093/ndt/gfv373. Epub 2015 Nov 10.

PMID:
26560811
4.

Acute acidosis attenuates leucine stimulated signal transduction and protein synthesis in rat skeletal muscle.

Sood S, Chen Y, McIntire K, Rabkin R.

Am J Nephrol. 2014;40(4):362-70. doi: 10.1159/000366524. Epub 2014 Oct 29.

PMID:
25358492
5.

Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease.

Wiezel D, Assadi MH, Landau D, Troib A, Kachko L, Rabkin R, Segev Y.

Nephrol Dial Transplant. 2014 Apr;29(4):791-9. doi: 10.1093/ndt/gfu003. Epub 2014 Jan 23.

PMID:
24463190
6.

Effect of armodafinil on cognition in patients with HIV/AIDS and fatigue.

McElhiney M, Rabkin J, Van Gorp W, Rabkin R.

J Clin Exp Neuropsychol. 2013;35(7):718-27. doi: 10.1080/13803395.2013.823910. Epub 2013 Aug 14.

7.

Acute uremia suppresses leucine-induced signal transduction in skeletal muscle.

McIntire KL, Chen Y, Sood S, Rabkin R.

Kidney Int. 2014 Feb;85(2):374-82. doi: 10.1038/ki.2013.216. Epub 2013 Jun 19.

8.

Epiphyseal growth plate growth hormone receptor signaling is decreased in chronic kidney disease-related growth retardation.

Troib A, Landau D, Kachko L, Rabkin R, Segev Y.

Kidney Int. 2013 Nov;84(5):940-9. doi: 10.1038/ki.2013.196. Epub 2013 May 29.

9.

The effects of type 1 IGF receptor inhibition in a mouse model of diabetic kidney disease.

Troib A, Landau D, Youngren JF, Kachko L, Rabkin R, Segev Y.

Growth Horm IGF Res. 2011 Oct;21(5):285-91. doi: 10.1016/j.ghir.2011.07.007. Epub 2011 Aug 23.

10.

A marked deficiency in circulating and renal IGF-I peptide does not inhibit compensatory renal enlargement in uninephrectomized mice.

Landau D, Biada J, Chen Y, Sood S, Yakar S, Leroith D, Segev Y, Rabkin R.

Growth Horm IGF Res. 2011 Oct;21(5):279-84. doi: 10.1016/j.ghir.2011.07.008. Epub 2011 Aug 23.

11.

Leucine-stimulated mTOR signaling is partly attenuated in skeletal muscle of chronically uremic rats.

Chen Y, Sood S, McIntire K, Roth R, Rabkin R.

Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E873-81. doi: 10.1152/ajpendo.00068.2011. Epub 2011 Jul 26.

12.

Treatment of HIV-related fatigue with armodafinil: a placebo-controlled randomized trial.

Rabkin JG, McElhiney MC, Rabkin R.

Psychosomatics. 2011 Jul-Aug;52(4):328-36. doi: 10.1016/j.psym.2011.02.005.

13.

Modafinil and armodafinil treatment for fatigue for HIV-positive patients with and without chronic hepatitis C.

Rabkin JG, McElhiney MC, Rabkin R.

Int J STD AIDS. 2011 Feb;22(2):95-101. doi: 10.1258/ijsa.2010.010326.

PMID:
21427431
14.

Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study.

Rabkin JG, McElhiney MC, Rabkin R, McGrath PJ.

J Clin Psychiatry. 2010 Jun;71(6):707-15. doi: 10.4088/JCP.09m05171bro. Epub 2010 May 4.

15.

Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation.

Chen Y, Biada J, Sood S, Rabkin R.

Kidney Int. 2010 Jul;78(1):89-95. doi: 10.1038/ki.2010.85. Epub 2010 Apr 7.

16.

Modafinil effects on cognitive function in HIV+ patients treated for fatigue: a placebo controlled study.

McElhiney M, Rabkin J, Van Gorp W, Rabkin R.

J Clin Exp Neuropsychol. 2010 Jun;32(5):474-80. doi: 10.1080/13803390903201769. Epub 2009 Nov 24.

17.

Endotoxin-induced growth hormone resistance in skeletal muscle.

Chen Y, Sood S, Krishnamurthy VM, Rotwein P, Rabkin R.

Endocrinology. 2009 Aug;150(8):3620-6. doi: 10.1210/en.2008-1703. Epub 2009 May 14.

18.

Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation.

Landau D, Eshet R, Troib A, Gurman Y, Chen Y, Rabkin R, Segev Y.

Endocrine. 2009 Aug;36(1):126-34. doi: 10.1007/s12020-009-9190-2. Epub 2009 Apr 23.

PMID:
19387875
19.

Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study.

Rabkin JG, Gordon PH, McElhiney M, Rabkin R, Chew S, Mitsumoto H.

Muscle Nerve. 2009 Mar;39(3):297-303. doi: 10.1002/mus.21245.

PMID:
19208404
20.

Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a pilot study.

McElhiney MC, Rabkin JG, Rabkin R, Nunes EV.

Am J Drug Alcohol Abuse. 2009;35(1):34-7. doi: 10.1080/00952990802342907.

21.

Low-dose growth hormone is cardioprotective in uremia.

Rabkin R, Awwad I, Chen Y, Ashley EA, Sun D, Sood S, Clusin W, Heidenreich P, Piecha G, Gross ML.

J Am Soc Nephrol. 2008 Sep;19(9):1774-83. doi: 10.1681/ASN.2007121386. Epub 2008 Jul 23.

22.

Increased workload fully activates the blunted IRS-1/PI3-kinase/Akt signaling pathway in atrophied uremic muscle.

Chen Y, Sood S, Biada J, Roth R, Rabkin R.

Kidney Int. 2008 Apr;73(7):848-55. doi: 10.1038/sj.ki.5002801. Epub 2008 Jan 23.

23.

Growth hormone treatment prevents osteoporosis in uremic rats.

Berger I, Piecha G, Rabkin R, Kaya N, Geldyyev A, Sun D, Chen Y, Koleganova N, Gross ML.

Histol Histopathol. 2007 Nov;22(11):1231-9. doi: 10.14670/HH-22.1231.

PMID:
17647196
24.

Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.

Chen Y, Sun D, Krishnamurthy VM, Rabkin R.

Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1856-62. Epub 2007 Feb 27.

25.

Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia.

Sun DF, Chen Y, Rabkin R.

Kidney Int. 2006 Aug;70(3):453-9. Epub 2006 Jun 28.

26.

Transcriptional profiling of aging in human muscle reveals a common aging signature.

Zahn JM, Sonu R, Vogel H, Crane E, Mazan-Mamczarz K, Rabkin R, Davis RW, Becker KG, Owen AB, Kim SK.

PLoS Genet. 2006 Jul;2(7):e115. Epub 2006 Jun 9.

27.

Circulating growth hormone binding protein levels and mononuclear cell growth hormone receptor expression in uremia.

Greenstein J, Guest S, Tan JC, Tummala P, Busque S, Rabkin R.

J Ren Nutr. 2006 Apr;16(2):141-9.

PMID:
16567271
28.

Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS.

Rabkin JG, McElhiney MC, Rabkin R, McGrath PJ, Ferrando SJ.

Am J Psychiatry. 2006 Jan;163(1):59-66.

PMID:
16390890
29.

Weight loss composition: the effects of exercise following obesity surgery as measured by bioelectrical impedance analysis.

Metcalf B, Rabkin RA, Rabkin JM, Metcalf LJ, Lehman-Becker LB.

Obes Surg. 2005 Feb;15(2):183-6.

PMID:
15802058
30.

Suppressors of cytokine signaling in health and disease.

Tan JC, Rabkin R.

Pediatr Nephrol. 2005 May;20(5):567-75. Epub 2005 Feb 19. Review.

PMID:
15723195
31.

Cardiac resistance to growth hormone in uremia.

Zheng Z, Sun DF, Tummala P, Rabkin R.

Kidney Int. 2005 Mar;67(3):858-66.

32.

Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling.

Rabkin R, Sun DF, Chen Y, Tan J, Schaefer F.

Pediatr Nephrol. 2005 Mar;20(3):313-8. Epub 2005 Feb 4. Review.

PMID:
15692835
33.

Modafinil treatment for fatigue in HIV+ patients: a pilot study.

Rabkin JG, McElhiney MC, Rabkin R, Ferrando SJ.

J Clin Psychiatry. 2004 Dec;65(12):1688-95.

PMID:
15641875
34.

Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.

Sun DF, Zheng Z, Tummala P, Oh J, Schaefer F, Rabkin R.

J Am Soc Nephrol. 2004 Oct;15(10):2630-6.

35.
36.

The duodenal switch as an increasing and highly effective operation for morbid obesity.

Rabkin RA.

Obes Surg. 2004 Jun-Jul;14(6):861-5. Review. No abstract available.

PMID:
15318996
37.

Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial.

Rabkin JG, Wagner GJ, McElhiney MC, Rabkin R, Lin SH.

J Clin Psychopharmacol. 2004 Aug;24(4):379-85.

PMID:
15232328
38.

New concepts: growth hormone, insulin-like growth factor-I and the kidney.

Rabkin R, Schaefer F.

Growth Horm IGF Res. 2004 Aug;14(4):270-6. Review.

PMID:
15231295
39.

Nutritional markers following duodenal switch for morbid obesity.

Rabkin RA, Rabkin JM, Metcalf B, Lazo M, Rossi M, Lehman-Becker LB.

Obes Surg. 2004 Jan;14(1):84-90.

PMID:
14980039
40.

Postoperative rhabdomyolysis following laparoscopic gastric bypass in the morbidly obese.

Khurana RN, Baudendistel TE, Morgan EF, Rabkin RA, Elkin RB, Aalami OO.

Arch Surg. 2004 Jan;139(1):73-6.

PMID:
14718280
41.

Albumin stimulates the accumulation of extracellular matrix in renal tubular epithelial cells.

Stephan JP, Mao W, Filvaroff E, Cai L, Rabkin R, Pan G.

Am J Nephrol. 2004 Jan-Feb;24(1):14-9. Epub 2003 Dec 3.

PMID:
14654729
42.

Diabetic nephropathy.

Rabkin R.

Clin Cornerstone. 2003;5(2):1-11. Review.

PMID:
12800476
43.

Laparoscopic technique for performing duodenal switch with gastric reduction.

Rabkin RA, Rabkin JM, Metcalf B, Lazo M, Rossi M, Lehmanbecker LB.

Obes Surg. 2003 Apr;13(2):263-8.

PMID:
12740136
44.

The role of growth factors and ammonia in the genesis of hypokalemic nephropathy.

Fervenza FC, Rabkin R.

J Ren Nutr. 2002 Jul;12(3):151-9. Review.

PMID:
12105812
45.
46.

Heart block in patients after bariatric surgery accompanying sleep apnea.

Block M, Jacobson LB, Rabkin RA.

Obes Surg. 2001 Oct;11(5):627-30.

PMID:
11594108
47.

Paradoxical body and kidney growth in potassium deficiency.

Fervenza F, Tsao T, Rabkin R.

Ren Fail. 2001 May-Jul;23(3-4):339-46.

PMID:
11499550
48.

Growth factor insensitivity in renal failure.

Rabkin R.

Ren Fail. 2001 May-Jul;23(3-4):291-300. Review.

PMID:
11499545
49.

Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia.

Schaefer F, Chen Y, Tsao T, Nouri P, Rabkin R.

J Clin Invest. 2001 Aug;108(3):467-75.

50.

[Depression and HIV].

Rabkin J, Rabkin R.

Sidahora. 1997 Oct-Nov:19-22. Spanish.

PMID:
11364948

Supplemental Content

Loading ...
Support Center